CARTILAGE REGENERATION AFTER TREATMENT WITH LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS IN THE KNEE. (April 2022) - Saxer, F.; Laurent, D.; Scotti, C.; Juras, V.; Hacker, S.; Cole, B.; Pasa, L.; Lehovec, R.; Szomolanyi, P.; Raithel, E.; Praestgaard, J.; Gamba, F.L.; et al.